CMY2601 Assignment 1 Semester 2 Due August 2026

UNIVERSITY OF SOUTH AFRICA
Use College of Law — School of Criminal Justice


⋄ ⋄ ⋄ ⋄ ⋄ ⋄ ⋄ ⋄ ⋄⋄


CMY2601: Crime Risk Perspectives

Assignment 01 — Semester 2, 2026

⋄ ⋄ ⋄ ⋄ ⋄ ⋄ ⋄ ⋄ ⋄⋄




CMY2601
Module Code:
Crime Risk Perspectives
Module Name:
Gender and Crime; Classification of Drugs
Essay Topic:
01
Assignment Number:
25
Total Marks:




Submitted in partial fulfilment of the require-
ments for Crime Risk Perspectives — UNISA 2026

, UNISA | CMY2601 Crime Risk Perspectives — Assignment 01



Contents


1 Question 1: Reasons Why Men Commit More Crime Than Women (10) 3

1.1 1.1 Definition of the Gender Gap in Crime . . . . . . . . . . . . . . . . . . . . . . . 3

1.2 1.2 Biological and Physiological Explanations . . . . . . . . . . . . . . . . . . . . 3

1.3 1.3 Social Learning and Differential Association . . . . . . . . . . . . . . . . . . . 4

1.4 1.4 Sex-Role and Feminist Theory . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

1.5 1.5 Control Theory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5

1.6 1.6 Developmental and Life-Course Explanations . . . . . . . . . . . . . . . . . . 5

1.7 1.7 Critical Assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

1.8 1.8 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6


2 Question 2: Classification of Drugs and Their Effects When Taken Excessively (15) 7

2.1 2.1 Definition of a Psychoactive Substance . . . . . . . . . . . . . . . . . . . . . 7

2.2 2.2 Classification Framework . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7

2.3 2.3 Stimulants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

2.4 2.4 Depressants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

2.5 2.5 Opioids (Narcotics) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

2.6 2.6 Hallucinogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9

2.7 2.7 Cannabinoids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9

2.8 2.8 Inhalants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9

2.9 2.9 Scale of the Problem in South Africa . . . . . . . . . . . . . . . . . . . . . . . 10

2.10 2.10 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10


Reference List 11




Page 2 of 12